Parker Waichman LLP

Parker Waichman LLP Responds to FDA Decision Requiring Vision Loss Warnings for Ozempic, Wegovy, Mounjaro, Zepbound, and Other GLP-1 Drugs

Landmark FDA Action Requires New Warnings About NAION, a Serious Eye Condition That Can Cause Sudden and Permanent Vision Loss PORT WASHINGTON, N.Y.,…